Back to MLTX
UBS Group AG MLTX Position History
MoonLake Immunotherapeutics • Healthcare
Quarters held
14
Latest value
$4.4M
Q3 2026
Peak value
$6.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1K |
| Q3 2025 | $576K |
| Q3 2025 | $22K |
| Q3 2025 | $6K |
| Q4 2025 | $3.1M |
| Q4 2025 | $4K |
| Q4 2025 | $59K |
| Q1 2026 | $15K |
| Q1 2026 | $52K |
| Q1 2026 | $6K |
| Q2 2026 | $21K |
| Q2 2026 | $6.4M |
| Q2 2026 | $6K |
| Q3 2026 | $4.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $4.4M | 377.3K | — | — |
| Q2 2026 | $6K | 300 | — | — |
| Q2 2026 | $6.4M | 327.1K | — | — |
| Q2 2026 | $21K | 1.1K | — | — |
| Q1 2026 | $6K | 300 | — | — |
| Q1 2026 | $52K | 2.8K | — | — |
| Q1 2026 | $15K | 802 | — | — |
| Q4 2025 | $59K | 4.5K | — | — |
| Q4 2025 | $4K | 300 | — | — |
| Q4 2025 | $3.1M | 234.3K | — | — |
| Q3 2025 | $6K | 820 | — | — |
| Q3 2025 | $22K | 3.0K | — | — |
| Q3 2025 | $576K | 80.3K | — | — |
| Q3 2025 | $1K | 209 | — | — |
Other funds holding MLTX
$311.5M
$298.3M
$260.3M
$256.4M
$192.9M
$191.2M
$187.2M
$182.6M